Stocks and Investing
Stocks and Investing
Wed, November 8, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Arthur He Maintained (BCAB) at Strong Buy with Decreased Target to $10 on, Nov 8th, 2023
Arthur He of HC Wainwright & Co., Maintained "BioAtla, Inc." (BCAB) at Strong Buy with Decreased Target from $17 to $10 on, Nov 8th, 2023.
Arthur has made no other calls on BCAB in the last 4 months.
There are 3 other peers that have a rating on BCAB. Out of the 3 peers that are also analyzing BCAB, 0 agree with Arthur's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Arthur
- Brian Cheng of "JP Morgan" Maintained at Buy with Decreased Target to $14 on, Monday, September 25th, 2023
- Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $12 on, Wednesday, August 2nd, 2023
- Tony Butler of "EF Hutton" Reiterated at Strong Buy and Held Target at $25 on, Wednesday, August 2nd, 2023
Contributing Sources